Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors.

PURPOSE To report the complication rate and risk factors of transrectally implanted gold markers, used for prostate position verification and correction procedures. METHODS AND MATERIALS In 209 consecutive men with localized prostate cancer, four gold markers (1 x 7 mm) were inserted under ultrasound guidance in an outpatient setting, and the toxicity was analyzed. All patients received a questionnaire regarding complications after marker implantation. The complications and risk factors were further evaluated by reviewing the medical charts. RESULTS Of the 209 men, 13 (6.2%) had a moderate complication, consisting of pain and fever that resolved after treatment with oral medication. In 1.9% of the men, minor voiding complaints were observed. Other minor transient complications, defined as hematuria lasting >3 days, hematospermia, and rectal bleeding, occurred in 3.8%, 18.5%, and 9.1% of the patients, respectively. These complications were seen more often in patients with advanced tumor stage, younger age, and shorter duration of hormonal therapy. CONCLUSION Transrectal gold marker implantation for high-precision prostate radiotherapy is a safe and well-tolerated procedure.

[1]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[2]  John T. Wei,et al.  Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. , 2006, International journal of radiation oncology, biology, physics.

[3]  M. Terris,et al.  Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. , 1998, The Journal of urology.

[4]  Michael G Herman,et al.  Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. , 2005, International journal of radiation oncology, biology, physics.

[5]  M. Roobol,et al.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. , 2002, Urology.

[6]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[7]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J Alfred Witjes,et al.  The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. , 2005, International journal of radiation oncology, biology, physics.

[9]  U. Norming,et al.  Complications following combined transrectal aspiration and core biopsy of the prostate. , 1990, Scandinavian journal of urology and nephrology.

[10]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[11]  B. Doré,et al.  Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. , 1997, British journal of urology.

[12]  L. Holmberg,et al.  Determinants of complications after multiple transrectal core biopsies of the prostate , 2004, European Radiology.

[13]  R. Bouvier,et al.  Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. , 2005, Cancer research.

[14]  Clifton D Fuller,et al.  Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[15]  Jan J W Lagendijk,et al.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  A. Passaniti,et al.  Altered angiogenesis underlying age-dependent changes in tumor growth. , 1994, Journal of the National Cancer Institute.

[17]  Randall K Ten Haken,et al.  Daily prostate targeting using implanted radiopaque markers. , 2001, International journal of radiation oncology, biology, physics.

[18]  G N Collins,et al.  Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance. , 1993, British journal of urology.

[19]  Jean Pouliot,et al.  (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. , 2003, International journal of radiation oncology, biology, physics.

[20]  R. Clements,et al.  Side effects and patient acceptability of transrectal biopsy of the prostate. , 1993, Clinical radiology.

[21]  F. Schröder,et al.  Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. , 1997, Urology.

[22]  H. Huisman,et al.  Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers. , 2005, Radiology.

[23]  J. Hugosson,et al.  Transrectal ultrasound examination of the prostate: complications and acceptance by patients. , 1993, British journal of urology.

[24]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[25]  A. Zlotta,et al.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. , 2001, The Journal of urology.

[26]  T Haycocks,et al.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[28]  V. Khoo,et al.  Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Frank Van den Heuvel,et al.  Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.